The association of dysglycaemia and cardiovascular disease in patients with metabolic syndrome

Journal of International Medical Research

Volumn 37, Issue 5, 2009, Pages 1486-1492

  Gong, W ^a   Yang, Z ^a   Ye, W ^a   Du, Y ^a   Lu, B ^a   Wang, M ^a   Li, Q ^a   Zhang, W ^a   Pan, Y ^a   Feng, X ^a   Zhou, W ^a   Zhang, Y ^a   Wen, J ^a   Yang, Y ^a   Zhu, X ^a   Hu, R ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Diabetes mellitus; Glucose intolerance; Insulin resistance; Metabolic syndrome

Indexed keywords

ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR DISEASE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ANKLE BRACHIAL INDEX; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHINA; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 77649219350     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/147323000903700525     Document Type: Article

References (18)

1. Reynolds K, He J: Epidemiology of the metabolic syndrome. Am J Med Sci 2005; 330: 273-279.
2. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769-1778.
3. Avramoglu RK, Basciano H, Adeli K: Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 2006; 368: 1-19
4. Genuth S, Alberti KG, Bennett P, et al: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
5. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.
6. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
7. Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
8. Kubo T, Miyata M, Minagoe S, et al: A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res 2002; 25: 351-358.
9. Gami AS, Witt BJ, Howard DE, et al: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414.
10. Ford ES, Li C, Sattar N: Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 2008; 31: 1898-1904.
11. Valantine H, Rickenbacker P, Kemna M, et al: Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study. Circulation 2001; 103: 2144-2152.
12. Saely CH, Aczel S, Marte T, et al: The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. J Clin Endocrinol Metab 2005; 90: 5698-5703.
13. Hu R, Ma CS, Nie SP, et al: Effect of metabolic syndrome on prognosis and clinical characteristics of revascularization in patients with coronary artery disease. Chin Med J (Engl) 2006; 119: 1871-1876.
14. American Diabetes Association: Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26: 3333-3341.
15. Raman PG, Thakur BS, Mathew V: Ankle brachial index as a predictor of generalized atherosclerosis. J Assoc Physicians India 2001; 49: 1074-1077.
16. Fujiwara Y, Chaves P, Takahashi R, et al: Relationships between brachial-ankle pulse wave velocity and conventional atherosclerotic risk factors in community-dwelling people. Prev Med 2004; 39: 1135-1142.
17. Bonadonna RC, Cucinotta D, Fedele D, et al: The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 2006; 29: 2701-2707.
18. Ferrannini E, Stern MP, Galvan AQ, et al: Impact of associated conditions on glycemic control of NIDDM patients. Diabetes Care 1992; 15: 508-514., 2013